| The PI3Kδ inhibitor roginolisib (IOA-244) preserves T-cell function and activity | Molecular oncology |  | | 2026 | 1 | 0 |
|
| A novel mitochondrial pyruvate carrier inhibitor drives stem cell-like memory CAR T cell generation and enhances antitumor efficacy | Molecular therapy. Oncology | | | 2024 | 216 | 190 |
|
| IOA-244 is a Non-ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance | Cancer research communications | | | 2023 | 153 | 74 |
|
| Reductive carboxylation epigenetically instructs T cell differentiation | Nature |  | | 2023 | 227 | 0 |
|
| Cytokine-armed dendritic cell progenitors for antigen-agnostic cancer immunotherapy | Nature cancer | | | 2023 | 337 | 363 |
|
| The mitochondrial pyruvate carrier regulates memory T cell differentiation and antitumor function | Cell metabolism | | | 2022 | 802 | 655 |
|
